|
CCDC18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.981500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.801100E-03 |
| Normal-vs-Stage2 |
1.376680E-04 |
| Normal-vs-Stage3 |
3.097600E-03 |
| Normal-vs-Stage4 |
1.125610E-02 |
| Stage1-vs-Stage2 |
6.521200E-03 |
| Stage1-vs-Stage3 |
3.758200E-01 |
| Stage1-vs-Stage4 |
7.674000E-01 |
| Stage2-vs-Stage3 |
1.081230E-01 |
| Stage2-vs-Stage4 |
8.470100E-02 |
| Stage3-vs-Stage4 |
7.322600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.324000E-03 |
| Normal-vs-AfricanAmerican |
2.715700E-03 |
| Normal-vs-Asian |
8.701600E-03 |
| Caucasian-vs-AfricanAmerican |
2.311200E-01 |
| Caucasian-vs-Asian |
7.227600E-01 |
| AfricanAmerican-vs-Asian |
5.217400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.459200E-03 |
| Normal-vs-Female |
2.482900E-03 |
| Male-vs-Female |
5.166600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.497500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.634100E-04 |
| Normal-vs-Age(61-80Yrs) |
6.426200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.948000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.240800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.984040E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.542450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.857800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.050050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.921670E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.625780E-01 |
| Classical-VS-Follicular |
1.183750E-02 |
| Classical-VS-Other |
3.164000E-01 |
| Classical-VS-Normal |
1.050120E-02 |
| Tall-VS-Follicular |
8.241600E-01 |
| Tall-VS-Other |
1.127180E-01 |
| Tall-VS-Normal |
2.216200E-03 |
| Follicular-VS-Other |
8.865900E-02 |
| Follicular-VS-Normal |
4.565000E-04 |
| Other-VS-Normal |
6.739000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.301420E-03 |
| Normal-vs-N1 |
1.750310E-02 |
| N0-vs-N1 |
3.222400E-01 |
|
|
